Article
Central neurocytoma – 30-day postoperative morbidity in a series of 30 patients
Zentrales Neurozytom: 30-Tage-Morbidität postoperativ bei einer Serie von 30 Patienten
Search Medline for
Authors
Published: | May 25, 2022 |
---|
Outline
Text
Objective: Neurocytomas are rare tumors. Due to their location they present a challenge for surgical treatment. We here investigated the 30-day morbidity after resection of central neurocytomas.
Methods: Analysis of demographic and clinical data of a series of 30 patients who had surgery over a 20-year period. The primary outcome determinant was the occurrence of complications within 30 days postoperatively.
Results: Eighteen patients were male (60%), 12 (40 %) were female. Mean age at surgery was 32 years (range, 12 to 84 years). A transcortical approach was chosen in 19 instances. Twenty patients had preoperative hydrocephalus and/or symptoms of increased intracranial pressure (66%). There were no intraoperative complications. An EVD was placed perioperatively in 8 patients (26.6%). Early postoperative complications occurred in 5 patients and included: ventricular hemorrhage (n=2), subdural hygroma (n=1) and neurologic deterioration (n=2).
Conclusion: The 30-day morbidity in patients with central neurocytomas is acceptable when surgery is performed in experienced hands. Management of CSF disorders in the acute phase is crucial.